Predicting disease progression and poor outcomes in patients with moderately active rheumatoid arthritis: a systematic review

OBJECTIVES: Access to biologic DMARDs for RA is often restricted to those with severe disease. This systematic review aimed to identify prognostic factors in patients with moderate disease activity who may be at risk of disease progression and poor clinical outcomes. METHODS: MEDLINE, Embase and Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Christopher J, Kiely, Patrick, Arthanari, Subhashini, Kiri, Sandeep, Mount, Julie, Barry, Jane, Mitchell, Catherine R, Field, Polly, Conaghan, Philip G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649936/
https://www.ncbi.nlm.nih.gov/pubmed/31431990
http://dx.doi.org/10.1093/rap/rkz002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649936/
https://www.ncbi.nlm.nih.gov/pubmed/31431990
http://dx.doi.org/10.1093/rap/rkz002

Ejemplares similares